Skip to main content

Department of Medicine Archives

Gene discoveries give new hope to people who stutter

Dec. 2, 2021—New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter.

Read more


Reid selected for clinical trial development program

Dec. 2, 2021—Vanderbilt's Sonya Reid, MD, MPH, has been selected to participate in the first cohort of the Bristol Myers Squibb Foundation Clinical Trial Diversity Career Development Program.

Read more


Study examines genetic risk for suicide attempt

Nov. 30, 2021—New research from Vanderbilt identifies the first replicated genomic region contributing to risk of suicide attempt and confirms that genetic risk for the trait is not driven solely by risk for psychiatric disorders.

Read more


‘Multi-omics’ reveals treatment option for breast cancer subtype

Nov. 18, 2021—  by Bill Snyder In a multidisciplinary collaboration, researchers at Vanderbilt University Medical Center and the University of Miami Miller School of Medicine have identified a subtype of triple-negative breast cancer (TNBC) that appears to be able to escape detection by the immune system and evade immunotherapy. Their report, published Nov. 1 in the journal...

Read more


Program extends palliative care knowledge to improve patient care

Nov. 18, 2021—A new resource at Vanderbilt is helping medical students, residents and even long-standing medical faculty to enhance their palliative care skills.

Read more


Six from VUMC among most highly cited researchers

Nov. 18, 2021—Six Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers.

Read more


Antimicrobial stewardship effort expanding reach

Nov. 18, 2021—The Vanderbilt Antimicrobial Stewardship Program recently expanded to the outpatient realm to provide more support for providers to optimize antibiotic use and delivery in the clinic setting.

Read more


New Department of Medicine roles push forward initiatives in clinical research

Nov. 15, 2021—T. Alp Ikizler, MD, director of Vanderbilt's Division of Nephrology and Hypertension, has been named vice chair for Clinical Research in the Department of Medicine.

Read more


Who’s who in the respiratory landscape

Nov. 15, 2021—A metatranscriptomics method developed by Vanderbilt researchers simultaneously characterizes viruses, microbiome and host response in nasal swabs, opening opportunities to explore molecular interactions directly in clinical samples.

Read more


VUMC team puts tool to reduce heart failure admissions to test

Nov. 11, 2021—Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.

Read more


New way to bEET insulin resistance

Nov. 11, 2021—Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.

Read more


International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes

Nov. 11, 2021—  by Jill Clendening Nearly 400 investigators and scientific trainees hailing from 25 different countries recently gathered virtually, across continents and time zones, to share their latest research related to the immunology of Type 1 diabetes during the 18th Immunology of Diabetes Society (IDS) Congress, co-hosted by Vanderbilt University Medical Center and the University of...

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more